Home > Insider Trading > Filing (0001209191-18-039681)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1237831	Globus Medical Inc	GMED	Surgical & Medical Instruments & Apparatus (3841)	043744954

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1329100	Eric Schwartz	Valley Forge Business Center 2560 General Armistead Avenue Audubon PA 19403	Senior Vp And General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class A Common Stock	Acquisiton	2018-06-25	10,000	$24.98	10,000	No	4	M	Direct
Class A Common Stock	Disposition	2018-06-25	8,444	$53.64	1,556	No	4	S	Direct
Class A Common Stock	Disposition	2018-06-25	1,556	$54.59	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Stock Option (Right to Buy Class A Common Stock)	Disposition	2018-06-25	10,000	$0.00	10,000	$24.98

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
41,000		2026-04-28	No	4	M	Direct

Footnotes

This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.24 to $54.16, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.29 to $54.81, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
These options were included in a grant of 75,000 options that was granted on May 3, 2016, and which vests over a four-year period with one-fourth (1/4) of the options granted vesting on April 28, 2017, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.